Delivery Order SPE2DB24D2101-SPE2DB25FKMSU
Award Date 7/24/25
Potential Completion Date 8/14/25
Potential Value $7.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Terlivaz 0.85 MG vials. The $1,830.96 firm-fixed-price contract has an ultimate completion date of October 12, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TERLIVAZ 0.85 MG VIALS, a pharmaceutical product, with a ceiling value of $29,548.32 and a performance period through May 12, 2025. The contract is a firm fixed-price delivery order, which is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a...
- This is a $7,297.56 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 0.85 mg vials of the medication Terlivaz. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of medical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TERLIVAZ 0.85 MG VIALS, a pharmaceutical product, with a ceiling value of $2,462.36. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 9, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $9,010.50 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 180 mg TRODELVY vials. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $1,219.11 to Amerisourcebergen Drug Corp, a leading global pharmaceutical sourcing and distribution services company. The contract is for the provision of TADLIQ 20 MG/5 ML SUSPENSION 150ML, a pharmaceutical product, with a completion date of February 13, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp,...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product TECVAYLI 153 MG/1.7 ML VIAL 1.7ML. The contract, valued at $23,824.28, has an ultimate completion date of April 11, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $7,240 delivery order to AmerisourceBergen Drug Corp on July 26, 2025, with an ultimate completion date of July 28, 2025. This firm fixed price contract, designated as a non-competitive award with no set-aside provisions, represents a child delivery order issued under a larger contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order...
- The U.S. Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a delivery order valued at $2,957.22 to AmerisourceBergen Drug Corp on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to be delivered to Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, headquartered in Pennsylvania...
- This is a $9,740.91 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of various pharmaceutical products and medical supplies to support TRICARE, the military healthcare program. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...